Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ANIK
Anika Therapeutics Inc
stock NASDAQ

At Close
Dec 26, 2025 3:59:52 PM EST
9.56USD+0.844%(+0.08)149,036
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-9.48)0
After-hours
Dec 26, 2025 4:00:30 PM EST
9.55USD-0.105%(-0.01)270
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 10, 2021
05:00PM EST  Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   GlobeNewswire Inc
Nov 18, 2021
04:01PM EST  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following investor conferences:   GlobeNewswire Inc
Nov 16, 2021
10:11AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021   Benzinga
04:41AM EST  Stephens & Co. Initiates Coverage On Anika Therapeutics with Overweight Rating, Announces Price Target of $55   Benzinga
Nov 5, 2021
09:32AM EDT  Anika Cuts FY21 Sales Growth Guidance From 11-14% Year Over Year To 9-11% YoY   Benzinga
09:32AM EDT  Anika Therapeutics Q3 Adj. EPS $0.05 Beats $(0.21) Estimate, Sales $39.54M Beat $36.32M Estimate   Benzinga
Nov 4, 2021
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Nov 1, 2021
09:00AM EDT  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on earlyintervention orthopedics, today announced that its Board of Directors has appointed Sheryl Conley as independent director, effective October 28, 2021.   GlobeNewswire Inc
Oct 18, 2021
09:00AM EDT  Anika to Issue Third Quarter 2021 Financial Results on Thursday,   GlobeNewswire Inc
Sep 30, 2021
09:09AM EDT  Anika Launches WristMotion Total Wrist Arthroplasty System At American Society For Surgery Of The Hand Annual Meeting   Benzinga
09:00AM EDT  Anika Launches the WristMotion Total Wrist   GlobeNewswire Inc
Sep 14, 2021
09:12AM EDT  Anika Therapeutics Announces Tactoset Injectable Bone Substitute Now FDA Cleared For Hardware Augmentation   Benzinga
09:00AM EDT  Tactoset Injectable Bone Substitute Now FDA Cleared   GlobeNewswire Inc
Sep 7, 2021
10:00AM EDT  Anika to Participate in the Morgan Stanley 19th Annual Global   GlobeNewswire Inc
Sep 1, 2021
10:05AM EDT  Anika to Debut Joint Preservation Portfolio at the 2021 AAOS   GlobeNewswire Inc
Aug 23, 2021
11:39AM EDT  Return on Capital Employed Insights for Anika Therapeutics   Benzinga
Aug 5, 2021
04:13PM EDT  Anika Therapeutics Q2 EPS $0.09 Beats $(0.06) Estimate, Sales $38.10M Beat $34.76M Estimate   Benzinga
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 19, 2021
10:00AM EDT  Anika to Issue Second Quarter 2021 Financial Results on Thursday,   GlobeNewswire Inc
Jul 16, 2021
10:15AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021   Benzinga
08:06AM EDT  UBS Initiates Coverage On Anika Therapeutics with Neutral Rating, Announces Price Target of $46   Benzinga
Jul 1, 2021
09:13AM EDT  Anika Therapeutics Highlights WristMotion Total Wrist Arthroplasty Surgery Performed   Benzinga
09:00AM EDT  First Anika WristMotion Total Wrist Arthroplasty   GlobeNewswire Inc
Jun 3, 2021
08:00AM EDT  Company details multi-year Joint Preservation strategy for accelerated revenuegrowth and profitability   GlobeNewswire Inc
Jun 2, 2021
08:20AM EDT  The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements   Benzinga
May 13, 2021
11:00AM EDT  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to host its 2021 Virtual Investor Day on Thursday, June 3, 2021 beginning at 9:00am EDT.   GlobeNewswire Inc
May 6, 2021
05:25PM EDT  Anika Therapeutics Sees FY21 Sales Growth In Joint Preservation, Restoration Upper 20% To Low 30% Year-Over-Year Growth, For Joint Pain Mgmt. Up In Low Single Digit Range, For Other Down In Mid Single Digit Range   Benzinga
05:23PM EDT  Anika Therapeutics Q1 EPS $0.06 Beats $(0.12) Estimate, Sales $34.30M Beat $32.20M Estimate   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 4, 2021
10:30AM EDT  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May:   GlobeNewswire Inc
Apr 15, 2021
05:15PM EDT  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2021 financial results after the close of the market on Thursday, May 6, 2021 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.   GlobeNewswire Inc
Apr 5, 2021
09:25AM EDT  Anika to Participate in the 20th Annual Needham Virtual Healthcare   GlobeNewswire Inc
Mar 11, 2021
12:15PM EST  Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present at the Sidoti Spring Virtual Investor Conference on Thursday, March 25, 2021 at 8:30 a.m. ET.   GlobeNewswire Inc
Mar 4, 2021
04:50PM EST  Recap: Anika Therapeutics Q4 Earnings   Benzinga
04:09PM EST  Anika Therapeutics Q4 Adj. EPS $0.12 Beats $(0.01) Estimate, Sales $32.70M Miss $33.50M Estimate   Benzinga
04:05PM EST  Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year,Full Year 2020 Revenue up 14%Well Positioned for Growth in 2021   GlobeNewswire Inc
08:12AM EST  The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company   Benzinga
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Feb 27, 2021
09:04PM EST  The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings   Benzinga
Feb 9, 2021
03:00PM EST  Anika to Issue Fourth Quarter and Year-End 2020 Financial   GlobeNewswire Inc
Dec 16, 2020
07:36AM EST  Barrington Research Upgrades Anika Therapeutics to Outperform, Announces $43 Price Target   Benzinga
Nov 4, 2020
04:22PM EST  Anika Therapeutics Q3 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $31.70M Beat $30.11M Estimate   Benzinga
04:06PM EST  Revenue Increased7% Year-over-Year to $31.7 MillionRepaid $25Million of Outstanding Credit FacilityContinued Expansion of Joint Preservation Product Portfolio   GlobeNewswire Inc
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 22, 2020
04:05PM EDT  Anika to Issue Third Quarter 2020 Financial Results and Business   GlobeNewswire Inc
Oct 21, 2020
04:10PM EDT  Anika Announces FDA 510(k) Clearance For Its WristMotion Total Arthroplasty System For The Replacement Of Painful Wrist Joints   Benzinga
04:05PM EDT  Anika Announces FDA 510(k) Clearance for its   GlobeNewswire Inc
Sep 8, 2020
04:54PM EDT  Board Chair Joseph Bower,D.B.A. announces intention not to stand for re-election at 2021 Annual MeetingJeffery Thompson succeeds Dr. Bower as Chair of the Board   GlobeNewswire Inc
Sep 3, 2020
02:35PM EDT  Anika to Participate in Upcoming Virtual Investor Conferences   GlobeNewswire Inc
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:19AM EDT  Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate   Benzinga
Aug 5, 2020
04:51PM EDT  Anika Appointed Michael Levitz As CFO   Benzinga
Jul 30, 2020
04:18PM EDT  Anika Therapeutics Q2 EPS $(0.54) Misses $(0.24) Estimate, Sales $30.70M Beat $20.37M Estimate   Benzinga
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 20, 2020
07:02AM EDT  Anika Therapeutics Announces 6 Minimally Invasive Surgical Products Have Been Approved by the FDA   Benzinga
07:00AM EDT  Anika To Launch Six FDA-Cleared Sports Medicine and Extremities   GlobeNewswire Inc
Jul 16, 2020
04:05PM EDT  Anika to Issue Second Quarter 2020 Financial Results and Business   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC